These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in σ2 Receptor-Expressing Cell Lines. Alamri MA; Ates-Alagoz Z; Adejare A Med Chem; 2020; 16(2):192-201. PubMed ID: 30827254 [TBL] [Abstract][Full Text] [Related]
47. Cytotoxic activities of hydroxyethyl piperazine-based σ receptor ligands on cancer cells alone and in combination with melphalan, PB28 and haloperidol. Korpis K; Weber F; Wünsch B; Bednarski PJ Pharmazie; 2014 Dec; 69(12):917-22. PubMed ID: 25951666 [TBL] [Abstract][Full Text] [Related]
48. Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites. Berardi F; Loiodice F; Fracchiolla G; Colabufo NA; Perrone R; Tortorella V J Med Chem; 2003 May; 46(11):2117-24. PubMed ID: 12747784 [TBL] [Abstract][Full Text] [Related]
49. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists. Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359 [TBL] [Abstract][Full Text] [Related]
50. Characterization of pulmonary sigma receptors by radioligand binding. Lever JR; Litton TP; Fergason-Cantrell EA Eur J Pharmacol; 2015 Sep; 762():118-26. PubMed ID: 26004528 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and binding affinity of cis-(-)- and cis-(+)-N-ethyleneamino-N-nordeoxymetazocine and cis-(-)-N-normetazocine analogues at sigma1, sigma2 and kappa opioid receptors. Ronsisvalle G; Prezzavento O; Marrazzo A; Vittorio F; Bousquet E; Di Toro R; Spampinato S Eur J Pharm Sci; 2001 Jan; 12(3):277-84. PubMed ID: 11113647 [TBL] [Abstract][Full Text] [Related]
52. Substituted 1-phenyl-2-cyclopropylmethylamines with high affinity and selectivity for sigma sites. Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Falcucci B; Di Toro RD; Spampinato S Bioorg Med Chem; 2000 Jun; 8(6):1503-13. PubMed ID: 10896126 [TBL] [Abstract][Full Text] [Related]
53. Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor. Alamri MA; Afzal O; Alamri MA SAR QSAR Environ Res; 2020 Nov; 31(11):837-856. PubMed ID: 33100033 [TBL] [Abstract][Full Text] [Related]
54. Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes. Oyer HM; Sanders CM; Kim FJ Front Pharmacol; 2019; 10():1141. PubMed ID: 31695608 [TBL] [Abstract][Full Text] [Related]
55. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site. Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (σ2) selective ligands. Ashford ME; Nguyen VH; Greguric I; Pham TQ; Keller PA; Katsifis A Org Biomol Chem; 2014 Feb; 12(5):783-94. PubMed ID: 24306445 [TBL] [Abstract][Full Text] [Related]
57. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Crawford KW; Bowen WD Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394 [TBL] [Abstract][Full Text] [Related]